Clonal expansion of p53 mutant cells is associated with brain tumour progression

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Nature

• Publication date

  1992-02-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/355846A0PMID 1311419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular themes in oncogenesis.

  1991cited by this paper
• Identification of p53 gene mutations in bladder cancers and urine samples.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Growth dominance of the metastatic cancer cell: cellular and molecular aspects.

  1990cited by this paper
• Mitotic recombination of chromosome 17 in astrocytomas.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Clonal genomic alterations in glioma malignancy stages.

  1988cited by this paper
• Specific chromosomal abnormalities in malignant human gliomas.

  1988cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• Pathology of Tumors of the Nervous System.

  1964cited by this paper

• Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions

  2025cites this paper
• Empowering rapid diagnosis and treatment of glioblastoma with biofunctionalized carbon quantum dots: a review

  2025cites this paper
• From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy

  2024cites this paper
• Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer

  2024cites this paper
• Convergent TP53 loss and evolvability in cancer

  2023cites this paper
• Extrinsic cell death pathway plasticity: a driver of clonal evolution in cancer?

  2022cites this paper
• Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma

  2022cites this paper
• Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery

  2022cites this paper
• Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness

  2022influential citation
• Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes.

  2022cites this paper
• Biologically Informed Clot Histomics Are Predictive of Acute Ischemic Stroke Etiology

  2022cites this paper
• A Systems Approach to Brain Tumor Treatment

  2021cites this paper
• Overcoming therapeutic resistance in glioblastoma: Moving beyond the sole targeting of the glioma cells

  2021cites this paper
• TP53 Mutation as Molecular Marker in the Assessment of Surgical Margin Status in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Glioblastoma multiforme: novel therapeutic targets

  2020cites this paper
• The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.

  2020cites this paper
• The Expression and Prognostic Value of p53 Gene in Invasive Ductal Carcinoma Breast: A Study in Mahatma Gandhi Memorial Medical College Indore M.P

  2019cites this paper
• The Expression and Prognostic Value of p 53 Gene in Invasive Ductal Carcinoma Breast : A Study in Mahatma Gandhi Memorial Medical College Indore

  2019cites this paper
• Relative Transcription Expression Level of SIRT1, SIRT2 and SIRT3 in Correlation to the Expression of a Set of Selected Cancer Related Genes in Human Breast Cancer

  2018cites this paper
• New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective

  2018cites this paper
• Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers

  2018cites this paper
• Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma

  2018cites this paper
• The role of CD133 in cancer: a concise review

  2018cites this paper
• Study of p 53 Gain of Function Mutations in p 53-null Astrocytes

  2018cites this paper
• Mutantelec: An In Silico mutation simulation platform for comparative electrostatic potential profiling of proteins

  2017cites this paper
• Citation classics in neuro-oncology: assessment of historical trends and scientific progress

  2017cites this paper
• Apoptosis gene network regulated by delta-tocotrienol in K562 chronic myeloid leukaemia cells

  2017cites this paper
• Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens

  2017cites this paper
• The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75NTR/CD271).

  2017cites this paper
• Key rates for the grades and transformation ability of glioma: model simulations and clinical cases

  2017cites this paper
• Glioblastoma targeted therapy: updated approaches from recent biological insights

  2017cites this paper
• XRCC1 rs25487 genetic variant and TP53 mutation at codon 249 predict clinical outcomes of hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A cohort study for 10 years’ follow up

  2016cites this paper
• Impact of Molecular Markers on Personalised-Treatment Concepts in Gliomas

  2016cites this paper
• IS ONCOLYTIC VIROTHERAPY A VIABLE PLATFORM FOR GLIOMA TREATMENT

  2016cites this paper
• Étude de nouveaux facteurs pronostiques de la survie des patients atteints de glioblastome : mutation IDH et invasivité radiologique estimée par modélisation biophysique

  2016cites this paper
• PATRICIA L. BLOUNT*t, STEPHEN J. MELTZERt, JING YINt, YING HUANGt, MARK J. KRASNA?,

  2016cites this paper
• Nanotechnology for cancer therapy

  2016cites this paper
• Oral cancer with special reference to virus detection and quantitative gene expression

  2016cites this paper
• Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

  2015cites this paper
• Adult High-Grade (Diffuse) Glioma

  2015cites this paper
• Primary Tumors of the Nervous System

  2015cites this paper
• Clonal diversity in glioblastoma: is it clinically relevant?

  2015cites this paper
• Targeted Therapy in Solid Tumors: Brain

  2015cites this paper
• Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets

  2015cites this paper
• Heterogeneity of c-Met expression in Chinese gastric cancer patients.

  2015cites this paper
• Genetic divergence and therapy-driven evolution between initial and recurrent glioma

  2014cites this paper
• New Aspects of the Clinicopathology and Genetic Profile of Metachronous Multiple Lung Cancers

  2014cites this paper
• Immunocompetent murine models for the study of glioblastoma immunotherapy

  2014cites this paper
• Impact of Molecular Markers on Personalised-Treatment Concepts in Gliomas

  2014cites this paper
• Molecular and genetic pathways in gliomas: the future of personalized therapeutics.

  2014cites this paper
• The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas

  2014cites this paper
• Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension

  2014cites this paper
• Emerging treatment strategies for glioblastoma multiforme

  2014influential citation
• Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases

  2014cites this paper
• Clinicopathology and Genetic Profile of Synchronous Multiple Small Adenocarcinomas: Implication for Surgical Treatment of an Uncommon Lung Malignancy

  2014cites this paper
• Connection between Cell Phone use, p53 Gene Expression in Different Zones of Glioblastoma Multiforme and Survival Prognoses

  2014cites this paper
• Investigating intratumour heterogeneity by single-cell sequencing.

  2013cites this paper
• Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step

  2013cites this paper
• Temozolomide-treated Human Glioblastoma Cells p53 Effects Both the Duration of G2/M Arrest and the Fate of

  2013cites this paper
• Primary Tumors of the Nervous System

  2013cites this paper
• Exploitation of adaptive evolution in glioma treatment.

  2013cites this paper
• Cancer heterogeneity: implications for targeted therapeutics

  2013cites this paper
• The molecular biology of WHO grade II gliomas.

  2013cites this paper
• The potential effects of Spirulina platensis (Arthrospira platensis) on tissue protection of Nile tilapia (Oreochromis niloticus) through estimation of P53 level

  2013cites this paper
• Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies

  2013cites this paper
• Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

  2013cites this paper
• The Molecular Biology of Diffuse Low-Grade Gliomas

  2013cites this paper
• A R T I C L E I N F O

  2013cites this paper
• The implications of clonal genome evolution for cancer medicine.

  2013cites this paper
• High Frequency of Temperature-Sensitive Mutants of p53 in Glioblastoma

  2013cites this paper
• Angiogenesis in Brain Tumors

  2013cites this paper
• TP53 Mutations in Canine Brain Tumors

  2012cites this paper
• Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States

  2012cites this paper
• Clonal evolution in cancer

  2012cites this paper
• 9 – Histopathology of brain tumors

  2012cites this paper
• Mechanistic Studies On the Role of Polyamines and Microvesicles in Tumor Growth and Hypoxia-mediated Angiogenesis

  2012cites this paper
• Genetic Driver Events in Premalignancy: LOH Validated for Marking the Risk of Oral Cancer

  2012cites this paper
• NovoTTF-100A: a new treatment modality for recurrent glioblastoma

  2012cites this paper
• Viral and molecular aspects of oral cancer.

  2012cites this paper
• Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.

  2012cites this paper
• Novel cancerization marker, TP53, and its role in distinguishing normal tissue adjacent to cancerous tissue from normal tissue adjacent to benign tissue

  2012cites this paper
• Estudo de alterações genéticas associadas à leucemia/linfoma de células T do adulto no estado da Bahia

  2012cites this paper
• lymphoblastic leukemia Mutations of the p53 and ras genes in childhood t(1;19)-acute

  2011cites this paper
• Angiogenesis , Metastasis , and the Cellular Microenvironment Progesterone and 1 , 25-Dihydroxyvitamin D 3 Inhibit Endometrial Cancer Cell Growth by Upregulating Semaphorin 3 B and Semaphorin 3 F

  2011cites this paper
• Molecular markers and bladder carcinoma: Schistosomal and non-schistosomal.

  2011cites this paper
• Progesterone and 1,25-Dihydroxyvitamin D3 Inhibit Endometrial Cancer Cell Growth by Upregulating Semaphorin 3B and Semaphorin 3F

  2011cites this paper
• gene in human leukemias Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16)

  2011cites this paper
• A furin/MMP-14 proteolytic cascade generates Vasculostatin-40 from extracellular BAI1: Implications for angiogenesis and tumorigenesis

  2011cites this paper
• always dependent on p53 gene mutations The expression of p53 protein in non-Hodgkin's lymphomas is not

  2011cites this paper
• WILMS’ TUMOR-1 (WT1) PROTEIN EXPRESSION IN GLIOMA CELLS ACTUATES CELLULAR INVASIVENESS- IDENTIFYING ITS TARGET GENES

  2011cites this paper
• Generation and analysis of mouse models of aberrant β-catenin function

  2011cites this paper
• NFκB inhibitors induce cell death in glioblastomas.

  2011cites this paper
• Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.

  2011cites this paper
• p53 in stem cells.

  2011cites this paper
• Ü-BOEFT#JPTDJFODF %POPUEJTUSJCVUF

  2011cites this paper
• Fos-related antigen-1 (Fra-1) is a regulator of glioma cell malignant phenotype

  2011cites this paper
• EGFR and p53 Status of Pulmonary Pleomorphic Carcinoma: Implications for EGFR Tyrosine Kinase Inhibitors Therapy of an Aggressive Lung Malignancy

  2011cites this paper
• Low-grade gliomas.

  2011cites this paper
• short survival in hematologic malignancies p53 mutations are associated with resistance to chemotherapy and

  2011cites this paper
• Pediatric Neuro-Oncology

  2010cites this paper